Alzheimer's Disease: Are we turning the corner? - The Biology Brief ep 7

Welcome to "The Biology Brief," your passport to the forefront of biology and innovation, proudly presented by Oleolive. Dive deep into the intricate world of Alzheimer's disease with Kiley Grant and Dr. Jim Cardelli in Episode 7 of "The Biology Brief" podcast! Join us as we unravel the foundations, breakthroughs, and challenges surrounding this complex condition. From New Antibody Therapeutics to the impact of Aducanumab, we explore the latest in Alzheimer's research. Discover the link between Alzheimer's and Type 2 Diabetes, delve into cutting-edge insights on Tau, and grasp the concept of Type 3 Diabetes. Explore global perspectives on Alzheimer's prevalence, biomarkers for personalized medicine, and innovative interventions. Join the conversation on neuroplasticity, rewiring, and the urgent call to action for proactive health measures.

Our company: https://www.oleo.live/

Buy Oligen here: https://oleocanthal.co/ What is alzheimer's disease 1:25 A hallmark of alzheimers - 2:55 New Antibody Therapeutics 3:46 amyloid beta 5:20 clinical trials 6:12 Aducanumab Breakthrough on treatment 7:36 AD is a Complex disease 9:19 What percent of AD patients have T2D 11:10 Pathways and new drugs 12:54 Clinical Trials Patient selection 16:02 Tau 18:42 Type 3 diabetes (AD) 20:00 Microglia Cells 22:46 Early Prevention AD, a disease of aging 24:10 Early Detection and Multimodal Prevention 26:57 Historical prevalence of AD 30:55 Bio markers for diagnosis and personalized medicine 32:00 Amyloid antibodies and side effects and cost 34:17 Drugs designed to target early disease 36:00 Patient recruitment problems for clinical trials 37:00 Is AD a western disease predominately? 39:32 Japan, Italy, Greece and lower rates of AD 40:30 Neuroplasticity and rewiring 42:05 Take responsibility for care of your health 43:00 Wrap up 43:36